Mendelian randomization provides genetic evidence in support of a causal role for coagulation factors (F8) and platelet activation (PDGFRL) in critical COVID-19 (Extended Data Table 2, Extended Data Fig. 7), consistent with autopsy6, proteomic38 and therapeutic39 evidence. This evidence concerns the gene PDGFRL and COVID-19.